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Abstract 
Background:  The sphingolipid glucosylceramide (GlcCer) and factors involved in the fungal GlcCer pathways were 
shown earlier to be an integral part of fungal virulence, especially in fungal replication at 37 °C, in neutral/alkaline 
pH and 5 % CO2 environments (e.g. alveolar spaces). Two mutants, ∆gcs1 lacking glucosylceramide synthase 1 gene 
(GCS1) which catalyzes the formation of sphingolipid GlcCer from the C9‑methyl ceramide and ∆smt1 lacking sphin‑
golipid C9 methyltransferase gene (SMT1), which adds a methyl group to position nine of the sphingosine back‑
bone of ceramide, of this pathway were attenuated in virulence and have a growth defect at the above‑mentioned 
conditions. These mutants with either no or structurally modified GlcCer located on the cell‑membrane have reduced 
membrane rigidity, which may have altered not only the physical location of membrane proteins but also their 
expression, as the pathogen’s mode of adaptation to changing need. Importantly, pathogens are known to adapt 
themselves to the changing host environments by altering their patterns of gene expression.
Results:  By transcriptional analysis of gene expression, we identified six genes whose expression was changed from their 
wild‑type counterpart grown in the same conditions, i.e. they became either down regulated or up regulated in these two 
mutants. The microarray data was validated by real‑time PCR, which confirmed their fold change in gene expression. All 
the six genes we identified, viz siderochrome‑iron transporter (CNAG_02083), monosaccharide transporter (CNAG_05340), 
glucose transporter (CNAG_03772), membrane protein (CNAG_03912), membrane transport protein (CNAG_00539), and 
sugar transporter (CNAG_06963), are membrane‑localized and have significantly altered gene expression levels. Therefore, 
we hypothesize that these genes function either independently or in tandem with a structurally modified cell wall/plasma 
membrane resulting from the modifications of the GlcCer pathway and thus possibly disrupt transmembrane signaling 
complex, which in turn contributes to cryptococcal osmotic, pH, ion homeostasis and its pathobiology.
Conclusion: Six genes identified from gene expression microarrays by gene set enrichment analysis and validated 
by RT‑PCR, are membrane located and associated with the growth defect at neutral‑alkaline pH due to the absence 
and or presence of a structurally modified GlcCer. They may be involved in the transmembrane signaling network in 
Cryptococcus neoformans, and therefore the pathobiology of the fungus in these conditions.
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Background
Cryptococcal meningitis is a leading cause of death in 
HIV patients [1]. It is caused by Cryptococcus neofor-
mans (Cn), an environmental fungus commonly found in 
pigeon droppings and eucalyptus trees. Though it is com-
monly known for its ability to cause disease in immuno-
compromised individuals, it has recently been recognized 
as a causative agent of infection in immunocompetent 
individuals too [2, 3]. Amongst the fungal virulence fac-
tors identified, the most important are their ability to 
survive in the host environments (acid-neutral-alkaline 
pH, 37 °C, 5 % CO2), capsule formation, urease and mela-
nin production (Reviewed in [4]).
Earlier reports had shown that the synthesis of fun-
gal sphingolipids regulates the ability of the fungus to 
replicate in the host environments [5–7]. In particular, 
studies in two mutants (∆gcs1 and ∆smt1) in the gluco-
sylceramide (GlcCer) pathway, lacking glucosylceramide 
synthase 1 and C9 sphingolipid methyltransferase 1 gene 
respectively, had shown that these genes are essential for 
the fungus to replicate in neutral-alkaline pH, 37 °C, 5 % 
CO2 (the physiological conditions found in the alveolar 
microenvironment). Upon intranasal injection, these 
mutants do not replicate in the lung and, thus, they are 
not pathogenic in a mouse model of cryptococcal men-
ingitis [6, 8, 9]. Both Δgcs1 and Δsmt1 mutants do not 
migrate from the lung to the brain because they are 
trapped in a lung granuloma.
In addition to be required for pathogenicity of Cn, the 
GlcCer pathway is also essential for the pathogenesis of 
other human pathogens, such as Candida albicans [10–
12] and Aspergillus fumigatus [13], and to plant patho-
gens, such as Fusarium graminearum [14]. Furthermore, 
the synthesis of GlcCer seems to be important during 
Pneumocystis pneumonia (PCP) as GlcCer synthase 
transcripts have been found to be abundant at the time 
of isolation of the fungus from fulminate lung infection 
[15], and for infection caused by dimorphic fungi, as Glc-
Cer is detected only in the lung infective form (yeast) and 
not in the environmental form (mold) [16–18]. Taken 
together, these studies suggest that the GlcCer pathway 
is most likely a pan-fungal virulence pathway required 
in promoting fungal replication at 37 °C, in neutral/alka-
line pH and 5 % CO2 environments (e.g. alveolar spaces), 
reviewed in [19].
GlcCer is a sphingolipid localized in cell membranes 
(mainly cell wall and plasma membranes) of Cn [20]. 
Structural studies had proposed the hypothesis that an 
alteration in the membrane lipid structure may result 
in an altered raft formation, thus affecting fungal mem-
brane fluidity and rigidity [21, 22]. Thus given its specific 
location and function in promoting fungal cell replica-
tion in neutral-alkaline pH, 37 °C, and 5 % CO2, GlcCer 
may be involved, either directly or indirectly in anchoring 
specific membrane proteins essential for transferring key 
nutrients across the membranes necessary for cell cycle 
progression.
Upon inhalation of fungal cells into the lung, Cn will 
have to adapt and respond to a new temperature, a new 
pH and to a new concentration of CO2. Several studies 
have highlighted fungal responses to the 37 °C tempera-
ture [23], pH [24–26] and to CO2 [27]. These studies 
suggested that replication of Cn in these microenviron-
ments requires maintenance of pH gradients across mul-
tiple membrane systems, regulation of inorganic carbon 
uptake and, most importantly, adjustment to changes in 
the abundances of different ions. In fact, transmembrane 
signaling complex have the potential to contribute to 
osmotic, pH and ion homeostasis [25, 26, 28]. Addition-
ally the physical structure of the plasma membrane can 
also change upon cell exposure to a different environ-
ment [29, 30], resulting in activation, down-regulation or 
dislocation of transmembrane transporters. This hypoth-
esis is supported by studies suggesting that a proper ratio 
of membrane sphingolipids and sterols is necessary to 
sustain the hydrophobicity of a transmembrane domain 
of certain channels regulating the transmembrane poten-
tial [31–33]. Thus, a change in the membrane framework 
occurring due to the changes in the composition and/or 
structure of membrane sphingolipids as reported earlier 
[9], could result in an alteration of membrane-spanning 
channels in these mutants.
In this study, we performed a transcriptional analysis 
of C. neoformans wild type, ∆gcs1 and ∆smt1 mutants 
grown at 37  °C, 5  % CO2 at either pH 4.0 or 7.2 ±  0.2. 
We then analyzed their gene expression profiles, focus-
ing only on genes whose expression was significantly 
changed at pH 7.2 ± 0.2 versus pH 4.0 in both ∆gcs1 and 
∆smt1 mutants but not in C. neoformans wild type and 
found six genes, all encoding for transmembrane trans-
porters. Quantitative real-time PCR (RT-PCR) was used 
to confirm the changes in expression of these six genes 
found by the microarray studies.
Methods
Strains and media
Cryptococcus neoformans var. grubii serotype A strain 
H99 wild-type (WT), C. neoformans ∆gcs1 mutant strain 
and C. neoformans ∆smt1 mutant strain, both derived 
from strain H99, were used in this study. Cryptococcus 
strains were routinely grown at 30 °C and 0.04 % atmos-
pheric CO2 in yeast peptone dextrose broth (YPD-1  % 
yeast extract, 2  % peptone, 2  % dextrose, BD). Dulbec-
co’s modified Eagle medium high glucose (DMEM high 
glucose), buffered with 50 mM HEPES, 10 % FBS (Fetal 
Bovine Serum) and 1 M sorbitol at pH 7.2 ± 0.2 or pH 4, 
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were used as conditioned media for growing C. neofor-
mans strains at 37 °C in presence of 5 % CO2.
RNA isolation
Overnight YPD grown cultures of WT, ∆gcs1 and ∆smt1 
mutant strain, were pelleted, washed twice with ster-
ile Phosphate Buffered Saline (PBS) and inoculated in 
DMEM high glucose, buffered with 50  mM HEPES, 
containing 10 % Fetal Bovine Serum, 1 M sorbitol at pH 
7.2 or pH 4 and shaken-incubated for 20 h at 37 °C, 5 % 
CO2. The cells were harvested by centrifugation at 5000g 
for 10  min and washed twice with PBS. The cell-pellets 
were flash-frozen in dry-ice/ethanol bath and stored at 
−80 °C until ready to use. Total RNA was extracted from 
Cn strains, as described previously [34]. Briefly, the cells 
were lyophilized overnight and 100 µl of lyophilized cells 
were transferred in 2  ml screw cap tubes and 1.25  ml 
of TRI reagent (Molecular Research Center, Inc.) was 
added. After homogenization, using Bead Beater 16, the 
tubes were incubated at room temperature for 10  min 
and centrifuged at 8000g to pellet cell debris and unbro-
ken cells. The supernatants were transferred in fresh 
tubes along with 60 µl of BAN phase separation reagent 
(Molecular Research Center, Inc., Cincinnati, OH, USA). 
After mixing for 20–30  s and incubating at room tem-
perature for 5  min, samples were centrifuged at 8000g. 
The aqueous phases were placed in fresh tubes along with 
70 % ethanol, and loaded onto RNeasy isolation columns 
provided by RNeasy Mini Kit (Qiagen, CA, USA). Total 
RNA was further purified and eluted according to manu-
facturer’s instructions. Total RNA integrity was verified 
by Agilent 2100 Bioanalyzer (Agilent, Santa Clara, CA, 
USA). Concentration and sample purity were determined 
by Nanodrop ND-1000 (Nanodrop, DE, USA). Samples 
with 260/280 < 1.8, 260/230 < 1.8 were column purified 
and re-quantitated.
Microarray experiment
Global gene expression changes due to different pH con-
ditions during growth were assessed for WT, ∆gcs1 and 
∆smt1 mutant strains on dual-channel Cy3-Cy5 Cryp-
tococcus neoformans H99 Agilent microarray (Agilent, 
Santa Clara, CA, USA). The array design is available on 
GEO (platform accession number GPL13419). Micro-
array analysis was carried out at MOgene, LC (Saint 
Louis, MO, USA). Total RNA (1  µg) was direct labeled 
using Kreatech ULS, a RNA Labeling Kit for dual-color 
hybridization. WT control strain grown at pH 4.0 were 
labeled with Cy3 (green channel) and the mutants or WT 
grown at 7.2  ±  0.2 pH labeled with Cy5 (red channel). 
Concentrations  and dye incorporation data (Cy3: 100–
130  pmol/µg, Cy5: 70–100  pmol/µg)  were determined 
by Nanodrop. After labeling, 300 ng of each sample were 
fragmented and hybridized to an Agilent custom anti-
sense probe 8 × 15 K microarray (AMADID 019465) by 
manufacturer’s specifications with the following excep-
tion: 5 µl of Kreablock (included in the labeling kit) was 
added after fragmentation. Hybridization was carried out 
in a SureHyb chamber in an Agilent hybridization oven at 
65 °C and 10 rpm for 17 h. Slides were washed using Agi-
lent GE wash buffers and scanned on an Agilent C scan-
ner at 5  µM. Data was extracted using Agilent Feature 
Extraction v. 10.7.1 software. The normalization method 
used for data extraction was Linear-Lowess. Raw data 
were expressed as Lowess-normalized log2 ratio (test/
reference).
Experiments involving 15 microarrays for 5 condi-
tions, conducted in triplicate, were used to compare WT 
to mutant expression at pH 4 and pH 7.2 ± 0.2. Entries 
in the associated data files included accession number, 
sequence description, and two intensity measurements, 
along with fold change estimate, and associated p value. 
Image processing, normalization, intensity estimation, 
and probe-level significance calculations were performed 
prior to this effort and data was taken from the files with-
out additional processing.
Quantitative real time PCR
cDNA was synthesized from 1  μg of the total RNA with 
SuperScript III RNase H-Reverse Transcriptase (Invitro-
gen) according to the manufacturer’s protocol. Real-time 
PCR was performed as described by Villani et al. [35] with 
some modifications. Briefly, 1 μl of cDNA, 1 μl each of for-
ward and reverse primers from 10  μM stocks, 12.5  μl of 
Bio-Rad iQ SYBR Green 2 X Supermix and 9.5 μl of ster-
ile water, were used for the qPCR reactions. All the reac-
tions were performed in triplicate. Primer sequences were 
as follows: CNAG_02083 (Siderochrome-iron-trans-
porter), forward: 5′-GCTTATCTTGCACTTACTGTCC 
TC-3′, reverse: 5′-TTTGGGAACAACGAGGTAGG-3′; 
CNAG_03912 (Membrane-protein), forward: 5′-GGTTTG 
CAAGGATTGATGCTTATC-3′, reverse: 5′-GTACGGTG 
GGTCAGAAAGGA-3′; CNAG_00539 (Membrane-trans-
port-protein), forward: 5′-ACGCCGATGGATTATTAC 
TAGC-3′, reverse: 5′-CGACCTAGCAGTTCCGAAAG-3′; 
CNAG_06963 (Sugar-transporter), forward: 5′-TGGTC 
CTATCGGTGACTACTCT-3′, reverse: 5′-GCCAACTT 
GAGACACAAGCA-3′; CNAG_05340 (Monosaccharide-
transporter), forward: 5′-AGGGATCGTTAGCTTTTGG 
TATG-3′, reverse: 5′-GGAAAATTGTTCGAGGACGA-3′; 
CNAG_03772 (Glucose-transporter), forward: 5′-GGA 
CTGGTGTCAACTTCATTTTC-3′, reverse: 5′-CGACAC 
CAATGATACCGACA-3′; CNAG_00334 (Heat-shock-
protein), forward: 5′-GAGTCGAGATCATCGCCAAC-3′, 
reverse: 5′-TTAACGTCAGCGTCGTCGTA-3′; CNAG_ 
03780 (Prcdna95), forward: 5′-AAGGGTGTCGTTGC 
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CTTCTAC-3′, reverse: 5′-ATAGCCAAAACCCTCCAT 
CC-3′; CNAG_00092 (Mitochondrial-protein), forward: 
5′-GACCCAAGACCATCTTCTTCT-3′, reverse: 5′-GCA 
GCGAGGGAGTAGTTGAC-3′; CNAG_01307 (Endoplas-
mic-reticulum-protein), forward: 5′-AGCGAAACTTGTA 
CTTGACAGG-3′, reverse: 5′-GCCATACTCGGCATTCT 
GTT-3′; CNAG_01150 (δ-12-fatty-acid-desaturase), for-
ward: 5′-CCTTGGCAGGTTCTCTCTTTCT-3′, reverse: 
5′-GCGTTGTTGATGGCCTTACT-3′. The amplification 
reactions consisted of 1 cycle of 3 min at 95 °C, 40 cycles 
of 10  s at 95  °C and 45  s at 55  °C, one cycle of 1  min at 
95 °C, one cycle of 1 min at 55 °C and 78 cycles of 10 s at 
55  °C. The results were normalized to an internal control 
gene, actin. Primer sequence was as follows: CNAG_00483 
(Actin), forward: 5′-ACATGTCTATGGAAGAAGAAGT 
CG-3′ reverse: 5′-ATACCGTGCTCAATGGGGTA-3′. The 
real-time PCR results were analyzed using Q-Gene® soft-




The conditions and file names for this data are given below 
in Table 1. All data is MIAME compliant and the raw data 
has been deposited in a MIAME compliant database with 
a GEO accession number GSE69361, a full description 
and complete data sets are available at (http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE69361).
In this effort we seek to identify groups of genes that 
are differentially regulated with patterns that correlate 
with the differential replication rates of the Cn WT and 
mutant strains. Earlier efforts indicated similar growth 
rates for the WT and ∆gcs1 or ∆smt1 mutants at pH 4, 
but with significantly reduced replication rate for the 
mutants, but not the WT, at neutral-alkaline pH. Thus, 
we focused on the analysis of gene expression profiles 
that would be associated with the pH phenotype. The Cn 
genome was acquired from the Cryptococcus grubii H99 
Database (http://www.broadinstitute.org/annotation/
genome/cryptococcus_neoformans/MultiHome.html). 
Descriptions and PFAM identifiers for each probe on the 
array were extracted from the genome information file 
after mapping probe accession numbers to locus identifi-
ers. Each probe was further annotated using Gene Ontol-
ogy (GO) terms taken from the PFAM2GO mapping. Of 
the 6931 probes, 3338 were annotated with one or more 
GO terms. This subset and the associated GO terms 
became the basis for our gene set enrichment analysis. 
For gene selection and or identification, signature pattern 
together with regression based methods were used.
Method 1—signature patterns
A gene is declared a signature gene within a microarray 
experiment if its fold changes p-value fall below 0.01. 
Furthermore, a gene is declared a signature gene for a 
specific condition if it was found to be a signature gene 
in all replicates of experiments for that condition. Finally, 
a gene is considered a signature gene for a pattern of 
conditions if that gene is a signature gene for all condi-
tions within the pattern and not a signature gene for any 
other conditions. Genes, therefore, are mapped into 1 of 
16 possible patterns arising from the 4 comparisons (WT 
vs ∆smt1 at pH 4, WT vs ∆smt1 at pH 7.2 ± 0.2, WT vs 
∆gcs1 at pH 4, WT vs ∆gcs1 at pH 7.2 ±  0.2). For each 
pattern, gene set enrichment analysis was conducted. Of 
particular interest in this study are genes that are differ-
entially expressed at pH neutral-alkaline pH but not at 
acidic pH, in both the mutants.
Method 2—regression
Concerned that signature gene selection criteria of 
Method 1 might be too restrictive, a regression-based 
analysis was also conducted. Observed log intensities are 
assumed to follow a linear model including array, pH, 
mutant, and gene effects and gene-pH, gene-mutant and 
gene-pH-mutant interactions. The regression model is 
given as
(1)log(Ii,j,k) = ai + pj +mk + gl + αl,j + βl,k + γl,j,k
Table 1 Growth conditions of  C. neoformans wild-type 
(WT) ∆gcs1 and ∆smt1 and corresponding microarray data 
file
Condition Data file
WT vs ∆smt1 pH 7.2 MUSC DelPoeta 102309 WT7.2 Cy3 MUT17.2 
Cy5_1
MUSC DelPoeta 102309 WT7.2 Cy3 MUT17.2 
Cy5_2
MUSC DelPoeta 011410 WT7.2 Cy3 MUT17.2 Cy5
WT vs ∆gcs1 pH 7.2 MUSC DelPoeta 102309 WT7.2 Cy3 MUT27.2 
Cy5_1
MUSC DelPoeta 102309 WT7.2 Cy3 MUT27.2 
Cy5_2
MUSC DelPoeta 011410 WT7.2 Cy3 MUT27.2 Cy5
WT vs ∆smt1 pH 4 MUSC DelPoeta 102309 WT4.0 Cy3 MUT14.0 
Cy5_1
MUSC DelPoeta 102309 WT4.0 Cy3 MUT14.0 
Cy5_2
MUSC DelPoeta 011410 WT4.0 Cy3 MUT14.0 Cy5
WT vs ∆gcs1 pH 4 MUSC DelPoeta 102309 WT4.0 Cy3 MUT24.0 
Cy5_1
MUSC DelPoeta 102309 WT4.0 Cy3 MUT24.0 
Cy5_2
MUSC DelPoeta 011410 WT4.0 Cy3 MUT240 Cy5
WT pH 4 vs WT pH 7.2 MUSC DelPoeta 011410 WT4.0S1 Cy3 WTS1 Cy5
 MUSC DelPoeta 011410 WT4.0S2 Cy3 WTS2 Cy5
 MUSC DelPoeta 011410 WT40S3 Cy3 WTS3 Cy5
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with Intensity Ii,j,k, effects for Array αi, pH pj, Mutant 
mk, and Gene gl and interactions αl,j, βl,k, and γl,j,k. The 
model was fit using Least Absolute Shrinkage and Selec-
tion Operator (LASSO) as implemented in the R glm-
net package [36] and the regression penalty parameter 
was chosen via cross-validation. Genes having non-zero 
gene-pH-mutant interactions for both mutants with 
effects in the same direction (coefficients having the 
same sign) were then selected for gene set enrichment 
analysis.
Gene set enrichment analysis
For genes mapped to each of the patterns under Method 
1 (signature patterns) and for the selected genes from 
Method 2 (regression), gene set enrichment analysis was 
performed. Only genes within the subset of 3338 and, 
thus, annotated with GO terms were used in this analy-
sis. Enrichment of GO-terms appearing within these 
groups of selected genes was assessed using the R topGO 
package version 1.16.0 [36] using the “classic” algorithm 
and “fisher” statistic. GO terms with p < 0.01 were con-
sidered significant.
A subset of six genes of interest, selected based on 
evidence of differential expression in the microar-
ray studies and labeled with GO terms found to be 
significant in our gene set enrichment analysis, were 
analyzed further using qRT-PCR. Based on minimal 
differential expression across conditions and high sig-
nal levels, five additional genes were selected using 
the microarray data and were used as a reference. 
The collection of these 11 genes was subjected to RT-
PCR for WT and mutants at pH 4 and pH 7.2 ± 0.2 (6 
cases).
The relationship between observed cycle time at 
threshold, CT, was assumed to be related to initial 
amount, A, the negative inverse of the log amplification 
efficiency, S, and the intercept of the linear approxima-
tion, I through the following expression.
The reference amount against which all experiments 
were normalized was taken from the average of the log 
amounts of the five reference genes. As such, the log nor-
malized expression for gene ‘g’ in strain ‘s’ under experi-
mental condition ‘e’ (pH) is given by
where the summation is over the five reference genes and 
Aref,e,g is the average log amount of the reference genes. 
Of interest in this analysis are the four ratios comparable 
to the microarray experiments.
(2)CT = S × log (A) + I
(3)















The model parameters S and I, the relative expressions 
for each experiment Ns, e,g and the ratios of interest 
Rg, were inferred using methods from the Bayesian sta-
tistical framework [37]. Inferences were accomplished 
using JAGS (3.1.0) [38] through the rjags package (3.10) 
[39] [40] within R. All inferences were executed in a sin-
gle step and CT measurements were assumed to share a 
common precision prior. A model burn-in of 50,000 sam-
ples preceded collection of 50,000 samples from which 
posterior credible intervals were determined.
A total of 381 genes were identified as signature genes 
in one or more of the conditions and 14 of the 16 pos-
sible signature patterns were associated with one or 
more signature genes (Table  2). All the genes mapped 
to their signature patterns were listed in additional file 1 
DOI “10.6070/H48050MW“ at https://mynotebook.
labarchives.com/share/Microarray/MjAuOHw5N-
DUwMy8xNi9UcmVlTm9kZS81ODE1Nzk3NTd8N-
TIuOA==. Of those 14 cases, 3 cases were found to 
have GO terms that were significantly enriched at the 
p  <  0.01 levels. These include (1) only WT vs ∆smt1 at 
pH 4, (2) only WT vs ∆smt1 at pH 7.2 ± 0.2 and WT vs 
∆gcs1 at pH 7.2 ± 0.2, and (3) only WT vs ∆gcs1 at pH 
7.2 ± 0.2. In case 1, significant GO terms were associated 
(4)








































Table 2 Signature patterns and  number of  genes identi-
fied in the experimental conditions













✓ ✓ 4 3✓ 37 15✓ ✓ ✓ 9 3✓ ✓ 14 3✓ ✓ 6 3✓ ✓ ✓ 2 2✓ ✓ ✓ ✓ 6 1✓ ✓ 17 8✓ 26 11✓ ✓ ✓ 2 1✓ ✓ 0 0✓ 50 16✓ ✓ 18 5✓ 190 83
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with cellular lipid metabolism and included GO:0006650 
glycerophospholipid metabolic process (p  =  0.0022), 
GO:0030384 phosphoinositide metabolic process 
(p  =  0.0022), GO:0046486 glycerolipid metabolic pro-
cess (p  =  0.0022), GO:0006644 phospholipid metabolic 
process (p = 0.0063), and GO:0019637 organophosphate 
metabolic process (p  =  0.0073) and in case 3 signifi-
cant terms included GO:0055114 oxidation reduction 
(p = 0.0016) and GO:0055085 transmembrane transport 
(p = 0.0025). Case 2, the case of greatest interest in this 
analysis, only GO:0055085 transmembrane transport 
(p = 0.0092) appeared significant with 4 of the 8 differen-
tially expressed and annotated genes being labeled with 
this GO term.
The regression-based analysis yielded similar find-
ings. A total of 207 genes were found to have non-zero 
gene-pH-mutant interactions where the estimated coef-
ficients were in the same direction for both mutants. 
Applying gene set enrichment analysis to the annotated 
subset of these genes identified 7 significantly enriched 
GO terms including GO:0055085 transmembrane 
transport (p = 3.3 × 10−5), GO:0055114 oxidation 
reduction (p  =  0.00013) GO:0032787 monocarbox-
ylic acid metabolic process (p = 0.00365), GO:0006810 
transport (p  =  0.00441), GO:0051234 establishment 
of localization (p  =  0.00441), GO:0051179 localiza-
tion (p =  0.00527), and GO:0008610 lipid biosynthetic 
process (p =  0.00574). Based on the results from both 
the signature and regression analyses, we selected 6 
genes that were differentially expressed and labeled 
with GO:0055085 (transmembrane transport) includ-
ing siderochrome-iron transporter (CNAG_02083), 
monosaccharide transporter (CNAG_05340), glu-
cose transporter (CNAG_03772), membrane pro-
tein (CNAG_03912), membrane transport protein 
(CNAG_00539), and sugar transporter (CNAG_06963). 
The products of these genes are all part of the major 
facilitator superfamily (MFS) (PFAM PF07690.8) which 
are secondary carriers transporting small solutes in 
response to chemiosmotic ion gradients. As further 
confirmation of these findings, the set of six genes were 
analyzed by q-RTPCR. Quantitative real-time RT-PCR 
validated the results of microarray gene expression pat-
terns. The credible intervals for both the microarray 
(orange and light blue) and PCR (red and dark blue) 
results are given in Fig.  1 for the six genes of interest 
and the five reference genes.
We see that siderochrome-iron transporter 
(CNAG_02083), membrane protein (CNAG_03912), and 
monosaccharide transporter (CNAG_05340), all exhibit 
expression that significantly exceeds the wild type in 
both mutants at pH 4 and expression significantly lower 
than that of the wild type at pH 7.2. The trend toward 
decreasing relative expression at pH 7.2 compared to pH 
4 is consistent with the results of the microarray experi-
ments. Interestingly, iron and/or glucose supplemen-
tation did not result in alteration of cell growth of the 
mutants Δgcs1, Δsmt1 at 37  °C, neutral/alkaline pH and 
5 % CO2 environments in comparison to the Cryptococ-
cus WT cultures (data not shown).
Discussion
Fungi are notoriously known for their ability to survive in 
a diverse range of environmental conditions. Especially, 
mammalian pathogens survive inside the infected host 
by adapting themselves to the unique stress of various 
microenvironments by successfully linking the expression 
of virulence-associated phenotypes to host-derived pH 
and temperature cues [41]. Aspergillus nidulans and Sac-
charomyces cerevisiae have the PacC/Rim101 transcrip-
tion factors mediating pH responses involving plasma 
membrane and endosomal signal complexes [24, 42]. In 
Candida albicans, Rim101 regulates the pH responsive 
pathway [43] involved in their transition from acidic to 
alkaline, which in turn stimulates a switch from yeast 
to filamentous form. Documented evidence of increase 
in GlcCer on the cell surface at alkaline pH in vitro [44] 
and also during infection, together with previous reports 
of GlcCer being associated with the ability to grow in 
alkaline pH, indicates therefore that this sphingolipid 
may play an important role in cryptococcal pH respon-
sive pathway. In addition to PKA pathway being involved 
in tolerating increased pH in Cryptococcus, a rim101 
mutant is hyper susceptible to not only elevated pH but 
also to iron deprivation [45].
In this study we have successfully used gene expression 
to identify genes differentially regulated in mutants defi-
cient in a sphingolipid GlcCer. Our microarray studies 
identified six genes, all of which are involved in transport-
ing ions or solutes across the plasma membrane. All of 
them have the conserved signature domain present in the 
Major Facilitator Superfamily members. CNAG_02083 
or the siderochrome iron transporter has partial homol-
ogy to MirA (siderphore transporter) of Fusarium and 
Aspergillus and to MFS of Candida. Similarly Aspergil-
lus and Candida also have the partial homologue of the 
monosaccharide transporter (CNAG_05340), the glucose 
transporter (CNAG_03772) and the membrane trans-
port protein (CNAG_00539), with no homologue as such 
in other fungi could be found for the membrane protein 
(CNAG_03912).
Membranes, being fluid, can sense changes in tem-
peratures, pH, and atmospheric pressure. In a living cell, 
membranes thus, may react by changes in phase state and 
their microdomain organization. This in turn modulates 
intracellular signaling, which activates transcription, 
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and thereby the activities of many membrane associated 
enzymes and transporters [46]. That these changes in 
protein activities are the direct read-outs of the expres-
sion of respective genes have been shown earlier in the 
case of heat shock genes [47] and also especially in many 
genes involved in lipid metabolism [48–50]. An impor-
tant relevant example can be the yeast PKC1 gene regu-
lated pathway which is activated by “plasma –membrane 
stretch” [51] resulting from its increased fluidity under 
conditions of thermal stress. Given this scenario, it is 
reasonable to hypothesize that the changes in membrane 
dynamics of the two mutants Δsmt1 and Δgcs1 impacted 
by its physical structure have resulted in the changed 
level of transcription of certain transporters located on 
the membrane.
In Cn, major phenotypic changes and the expression of 
virulence factors are regulated by ion-uptake and homeo-
stasis. More specifically, in addition to reduced fungal 
burden in mice brains infected with a mutant deficient 
in iron transporter, low iron induces capsule enlarge-
ment and represses laccase [52]. Cir1 considered as the 
master iron regulator controls the transcription of the 
genes involved in iron uptake and iron homeostasis and 
henceforth virulence in Cn [52]. The transcription of 
siderochrome iron transporter gene is modified in a cir1 
mutant, which eventually shows attenuation in virulence 
[53]. Altered iron and sugar homeostasis can result in a 
change in the melanin production, membrane trafficking 
and or copper or zinc loading. Our unpublished results 
demonstrating iron and/or sugar supplementation being 
unable to rescue the growth impairment in the mutants 
indicate that irreversible change/s in the physical struc-
ture of the membrane and hence some downstream sign-
aling complex associated with the membrane may have 
happened in the two mutant strains Δgcs1 and Δsmt1. 
Thus, taken together, this may be a causal factor for 
Fig. 1 Results of microarray gene expression patterns validated by RT‑PCR. The credible intervals for both the microarray (orange and light blue) 
and PCR (red and dark blue) results are for the six genes of interest and the five reference genes. The orange, red are results for ∆gcs1, while light blue, 
dark blue are for ∆smt1 respectively. The six genes of interest are siderochrome‑iron transporter (CNAG_02083), membrane protein (CNAG_03912), 
membrane transport protein (CNAG_00539), sugar transporter (CNAG_06963), monosaccharide transporter (CNAG_05340), glucose transporter 
(CNAG_03772). The five reference genes are heat shock protein (CNAG_00334), prcDNA95 (CNAG_03780), mitochondrial protein (CNAG_00092), 
endoplasmic reticulum protein (CNAG_01307), δ‑12 fatty acid desaturase (CNAG_01150)
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impaired growth at this pH and hence attenuated viru-
lence in these two mutants.
To facilitate comparison of the RT-PCR and microarray 
studies we sought a mathematical model that related the 
RT-PCR observations (measures of cycle time at thresh-
old for each gene, condition, and strain) to the ratios 
observed in the microarray studies (Rg, 1–4) for each 
of the genes of interest. Additionally, we sought to esti-
mate those ratios in a manner that accounts for correla-
tions in uncertainty when using common reference genes 
across our experimental conditions and strains using the 
wild type, under comparable conditions, as reference. To 
meet these objectives, we chose to express the relation-
ships between the experimentally observed data and the 
ratios of interest in a single model and to use computa-
tional methods from the Bayesian statistical framework 
to make the required inferences. This process provided 
posterior density estimates for each of the ratios of inter-
est and these results could then be directly compared 
to the microarray experiments (as shown in Fig. 1). The 
measures and the number of genes used in our refer-
ence set (5) are comparable to measures used to select 
genes developed by other commonly used software (e.g. 
geNorm which suggest 3–5). Similarly, the equations 
suggested by others (e.g. REST) are equivalent to those 
employed here. For confirmation of the reference gene 
as set selection, we plotted both microarray and RT-PCR 
expression changes and credible intervals for the refer-
ence set under variation in strain and pH in Fig. 1.
Some degree of variability in between our microar-
ray data was found in the genes CNAG_00539 and 
CNAG_03772, though the RT-PCR data were consistent 
with the microarray data within credible intervals. Gene 
set enrichment analysis was advantageous over individual 
gene analysis as it detected subtle changes in expression, 
although verification of hits after gene-set enrichment 
analysis was only feasible because of a small subset of six 
genes identified. However, overall, in this study, in the use 
of microarray, we overcame the challenge of analyzing a 
huge amount of expression data, and simultaneously fil-
ter out the false-positives effectively by following a sim-
ple multi-pronged approach of selecting genes through 
gene set enrichment analysis on selected genes mapped 
through signature patterns along with a regression-based 
approach and their functional validation.
Conclusion
Gene expression microarrays on WT and the mutants 
of the GlCer pathway identified a novel set of differen-
tially regulated genes associated with the growth of Cn 
in neutral-alkaline pH, 37  °C, 5  % CO2. Using both sig-
nature gene selection method and a regression –based 
analytical model, gene set enrichment analysis finally 
zeroed-in on a subset of six genes: siderochrome-iron 
transporter, monosaccharide transporter, glucose trans-
porter, membrane protein, membrane transport protein, 
and sugar transporter which were further validated by 
RT-PCR. These set of genes may therefore be involved 
in the down-stream transmembrane signaling network, 
connected to the GlcCer of the membrane, and therefore 
in-turn control the pathogen’s virulence—associated phe-
notype of growth defect in neutral-alkaline pH at 37 °C. 
Further studies will evaluate the role of these genes in the 
pathogenesis of C. neoformans and can answer specific 
mechanistic questions like how they are regulated when 
GlcCer is absent or its structure is altered.
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